Clinical Trials Logo

Clinical Trial Summary

As many as 250 million people suffer from allergic rhinitis in China, which has a large population, early use of drugs may help better control the symptoms.This study aimed to investigate the effects of early interventional treatment with the leukotriene receptor antagonist (LTRA) montelukast on seasonal allergic rhinitis.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05040828
Study type Interventional
Source Beijing Tongren Hospital
Status Completed
Phase Phase 4
Start date July 1, 2020
Completion date November 10, 2020

See also
  Status Clinical Trial Phase
Completed NCT00656058 - Montelukast to Treat Bronchiolitis Obliterans Phase 2